Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 554-92-7 Chemical Structure| 554-92-7

Structure of Trimethobenzamide HCl
CAS No.: 554-92-7

Chemical Structure| 554-92-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Trimethobenzamide HCl is a dopamine D2 receptor antagonist and antiemetic drug.

Synonyms: Ro 2-9578; Trimethobenzamide (hydrochloride); Trimethobenzamide hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Trimethobenzamide HCl

CAS No. :554-92-7
Formula : C21H29ClN2O5
M.W : 424.92
SMILES Code : O=C(NCC1=CC=C(OCCN(C)C)C=C1)C2=CC(OC)=C(OC)C(OC)=C2.[H]Cl
Synonyms :
Ro 2-9578; Trimethobenzamide (hydrochloride); Trimethobenzamide hydrochloride
MDL No. :MFCD00057999
InChI Key :WIIZEEPFHXAUND-UHFFFAOYSA-N
Pubchem ID :68385

Safety of Trimethobenzamide HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H317-H334
Precautionary Statements:P261-P280-P284-P301+P312+P330-P304+P340-P342+P311
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Trimethobenzamide HCl

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00626327 Meningococcal Infections Phase 3 Completed - -
NCT00626327 - Completed - -
NCT00806195 - Completed - -
NCT01345630 HIV-1 Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02556372 Autoimmune Hepatitis Phase 2 Active, not recruiting December 2018 United States, California ... More >> Ruane Clinical Research Group, Inc. Los Angeles, California, United States, 90036 University of California Davis Medical Center - Ticon 1 Sacramento, California, United States, 95817 California Pacific Medical Center San Francisco, California, United States United States, Florida University of Florida Hepatology Research at CTRB Gainesville, Florida, United States, 32610-0272 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Louisiana Tulane University New Orleans, Louisiana, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas Methodist Dallas Medical Center Dallas, Texas, United States, 75203 Advanced Liver Therapies, Baylor College of Medicine Houston, Texas, United States, 77030 The Texas Liver Institute San Antonio, Texas, United States, 78215 Taxes Liver Institute San Antonio, Texas, United States United States, Washington Swedish Medical Center - Organ Transplant and Liver Center Seattle, Washington, United States, 98104 University of Washington Seattle, Washington, United States, 98104 Less <<
NCT00834704 Solid Tumor Phase 1 Completed - United States, Arizona ... More >> T Gen Clinical Research Services Scottsdale, Arizona, United States, 85258 United States, California Premiere Oncology Santa Monica, California, United States, 90404 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT00397748 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00806195 Meningitis Me... More >>ningococcal Infection Less << Phase 3 Completed - -
NCT01345630 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01882465 Refractive Error Not Applicable Terminated - Hong Kong ... More >> Hong Kong Polytechnic University Hong Hom, Kowloon, Hong Kong Less <<
NCT01882465 - Terminated - -
NCT00029510 Asthma Phase 2 Completed - United States, California ... More >> University of California at Davis School of Medicine, Ticon 1, Suite 100B, 2000 Stockton Blvd Sacramento, California, United States, 95817 Less <<
NCT02373072 Idiopathic Parkinson Disease Phase 1 Completed - United States, California ... More >> Collaborative Neuroscience Network, LLC. Long Beach, California, United States, 90806 United States, Florida MD Clinical Hallandale, Florida, United States, 33009 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, Maryland SNBL Clinical Pharmacology Center, Inc. Baltimore, Maryland, United States, 21201 Parkinson's Movement Disorder Center of Maryland Elkridge, Maryland, United States, 21075 United States, Texas Neurology Consultants of Dallas, PA Dallas, Texas, United States, 75231 Walnut Hill Medical Center Dallas, Texas, United States, 75231 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01770145 Parkinson's Disease ... More >> Motor Symptoms Akinesia Hypomobility Delayed Levodopa Onset Less << Phase 4 Completed - United States, California ... More >> Keck School of Medicine Los Angeles, California, United States, 90033 Neurosearch, Inc. Reseda, California, United States, 91335 United States, District of Columbia Georgetown University Washington, D.C., District of Columbia, United States, 20007 United States, Florida Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton, Florida, United States, 33486 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Michigan Henry Ford West Bloomfield Hospital Bloomfield Hills, Michigan, United States, 48322 United States, New York Parkinson's Disease and Movement Disorders Center of New York Commack, New York, United States, 11725 United States, Ohio University of Cincinnati Academic Health Center Cincinnati, Ohio, United States, 45267 University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oklahoma The Movement Disorder Clinic of Oklahoma Tulsa, Oklahoma, United States, 74136 United States, Texas University of Texas Health Science Center, Houston, Department of Neurology Houston, Texas, United States, 77030 Center for Neurological Care and Research San Antonio, Texas, United States, 78240 Less <<
NCT01770145 - Completed - -
NCT00489255 Parkinson's Disease Phase 4 Completed - -
NCT02262767 Healthy Phase 1 Completed - Belgium ... More >> Belgium Pfizer Clinical Research Unit Brussels, Belgium, 1070 Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT00489255 - Completed - -
NCT00536185 Heart Disease Not Applicable Completed - United States, California ... More >> UC Davis, Western Human Nutrition Research Center Davis, California, United States, 95616 Ethnich Health Institute Oakland, California, United States, 94609 UC Davis (TICON-1) Sacramento, California, United States, 95820 Less <<
NCT03164551 Infertility Phase 4 Recruiting March 30, 2020 Canada ... More >> Cambrian Wellness Centre Recruiting Calgary, Canada, T3B 4N2 Denmark Skive Fertility clinic Recruiting Skive, Denmark, 7800 France Hopital Antoine Beclere Not yet recruiting Clamart, France, 92140 Italy Krankenhaus Bruneck Not yet recruiting Bruneck (BZ), Italy, I-39031 Demetra S.R.L Not yet recruiting Firenze, Italy, 50141 Futura Diagnostica medica PMA SRL Not yet recruiting Firenze, Italy, SO129 Unita' di medicina della riproduzione - centro Hera Withdrawn Sant'Agata Li Battiali(CT), Italy, 95030 USL Toscana Nordovest Not yet recruiting Viareggio, Italy, 55043 Norway Oslo University Hospital Recruiting Oslo, Norway Contact    +49 6151 72 5200       Sykehuset Telemark HF Fertilitetsavdeliningen Sor Recruiting Skien, Norway, 3710 St. Olavs Hospital Hf, Universitetssykehuset i Trondheim Recruiting Trodheim, Norway, N-7006 Portugal Centro Hospitalar e Universitario de Coimbra Recruiting Coimbra, Portugal, 3000-075 Spain Hospital de Cruces Recruiting Baracaldo, Spain, 48903 Nephrology Service Fundacion Puigvert Recruiting Barcelona, Spain, 8025 Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain Hosp Univ de Canarias Not yet recruiting Santa Cruz de Tenerife, Spain United Kingdom Barts Health Centre for Reproductive medicine Withdrawn London, United Kingdom, EC1A7BE Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.24mL

11.77mL

2.35mL

1.18mL

23.53mL

4.71mL

2.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories